A machine-learning digital twin for predicting vasopressor need in sepsis patients
Methylene blue as secondary vasopressor in septic shock: a single-center randomized controlled trial
Our experience with angiotensin 2: a mixed ICU perspective
Early identification of responders to angiotensin ii in distributive shock: a real-world hemodynamic and endocrine-based approach
Renin-guided initiation of angiotensin II in catecholamine-refractory septic shock: an open-label randomized controlled trial
Time-weighted mean vasopressor dose and clinical outcomes in a cohort of patients with septic shock
Safety-aware reinforcement learning for vasopressor weaning in septic ICU patients
Vasopressor use does not worsen sublingual microcirculation in a porcine model of non-traumatic hemorrhagic shock
Impact of vasopressor administration on peripheral perfusion assessed by temperature gradient during severe hemorrhagic shock
